there is progress in the fight against Alzheimer’s disease, the incurable brain condition that affects more than six million Americans. Several new drugs have shown small but positive results in ...

When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as ...

The results disclosed on Tuesday are from a trial called Refocus-ALZ, in which the drug failed to significantly reduce cognitive decline in patients with mild-to-moderate Alzheimer's disease.

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. In a paper ...

About this content. It might be difficult to understand just how tough a diagnosis of Alzheimer’s disease can be for an individual and their family until you have experienced it personally.